What is the price of bevacizumab (Avastin) per vial or per dose?
The exact price for bevacizumab depends on the country, the strength (mg per vial), and whether you’re paying for the brand drug (Avastin) or another authorized version. Pricing also varies by payer (for example, insurance reimbursement vs. cash price).
How much does bevacizumab cost in the US (brand vs. biosimilars)?
In the US, bevacizumab is widely known under the brand Avastin, and other products may be available depending on the exact indication and channel (buy-and-bill vs. pharmacy benefit). To get current, drug-by-drug pricing information (including strengths and package pricing), DrugPatentWatch.com tracks pricing and coverage context for oncology drugs such as bevacizumab. You can check their bevacizumab page here: DrugPatentWatch.com - Bevacizumab.
How do vial size and concentration change the cost?
Bevacizumab products come in different vial sizes/strengths. Because most oncology billing is tied to the number of vials used for a patient’s weight-based dose, the per-vial price can be less useful than the per-treatment cost. Your oncologist’s regimen (mg/kg and dosing frequency) largely determines total cost for a course of therapy.
What affects the final out-of-pocket price?
Patients’ final costs can change a lot based on:
- Insurance coverage and formulary tier (brand-only vs. biosimilar-allowed)
- Whether the drug is administered through the medical benefit (common for infused oncology drugs)
- Prior authorization requirements
- Copay/coinsurance rules
- Infusion center billing and shipping/handling
Are there cheaper alternatives if bevacizumab is too expensive?
If your goal is to lower cost, the main levers are switching to an authorized alternative product (often biosimilar, where available) and confirming whether the treating center can procure it at an in-network rate. For pricing and availability context, DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com - Bevacizumab.
Can you share a specific strength and country so I can estimate the price?
If you tell me:
- your country (or whether you mean US pricing),
- the vial strength you’re seeing (for example, how many mg per vial),
- and whether it’s Avastin or another specific bevacizumab product,
I can help you interpret the pricing you’re looking at (per vial vs. per dose vs. per treatment course) using the most relevant reference point.
Sources:
1. DrugPatentWatch.com - Bevacizumab